ES2174486T3 - Ensayo multicelular in vitro de angiogenesis. - Google Patents

Ensayo multicelular in vitro de angiogenesis.

Info

Publication number
ES2174486T3
ES2174486T3 ES98944120T ES98944120T ES2174486T3 ES 2174486 T3 ES2174486 T3 ES 2174486T3 ES 98944120 T ES98944120 T ES 98944120T ES 98944120 T ES98944120 T ES 98944120T ES 2174486 T3 ES2174486 T3 ES 2174486T3
Authority
ES
Spain
Prior art keywords
angiogenesis
vitro
test
multicellular
combined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98944120T
Other languages
English (en)
Inventor
Eileen Tennant Grant
Graham Thomas Bell
Stephen Bloor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocure Ltd
Original Assignee
Biocure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocure Ltd filed Critical Biocure Ltd
Application granted granted Critical
Publication of ES2174486T3 publication Critical patent/ES2174486T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un ensayo multicelular in vitro para reproducir el modelo de las fases combinadas de la angiogénesis, es decir, las fases de proliferación, migración y diferenciación del desarrollo de las células, en el cual el ensayo comprende proporcionar un cultivo doble de células endoteliales junto con fibroblastos que presenten interacción con éstas, siendo facilitadas dichas células al cultivo doble en el cual la proporción de fibroblastos respecto de las células endoteliales es de aproximadamente 2:1 a 8:1, en la cual dichos fibroblastos forman una monocapa en la cual las células endoteliales ofrecen las fases combinadas de angiogénesis de modo que se puedan controlar las fases respectivas de angiogénesis durante un período de tiempo predeterminado.
ES98944120T 1997-10-01 1998-09-25 Ensayo multicelular in vitro de angiogenesis. Expired - Lifetime ES2174486T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9720987.8A GB9720987D0 (en) 1997-10-01 1997-10-01 A multicellular in vitro assay of angiogenesis

Publications (1)

Publication Number Publication Date
ES2174486T3 true ES2174486T3 (es) 2002-11-01

Family

ID=10819980

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98944120T Expired - Lifetime ES2174486T3 (es) 1997-10-01 1998-09-25 Ensayo multicelular in vitro de angiogenesis.

Country Status (15)

Country Link
EP (1) EP1023599B1 (es)
JP (1) JP3404572B2 (es)
AT (1) ATE218209T1 (es)
AU (1) AU732538B2 (es)
CA (1) CA2301171C (es)
DE (1) DE69805644T2 (es)
DK (1) DK1023599T3 (es)
ES (1) ES2174486T3 (es)
GB (1) GB9720987D0 (es)
IL (1) IL135386A0 (es)
MY (1) MY119061A (es)
NO (1) NO20001608L (es)
NZ (1) NZ502962A (es)
WO (1) WO1999017116A1 (es)
ZA (1) ZA988936B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151847B2 (en) 2001-02-20 2006-12-19 Cytokinetics, Inc. Image analysis of the golgi complex
US6743576B1 (en) 1999-05-14 2004-06-01 Cytokinetics, Inc. Database system for predictive cellular bioinformatics
US6651008B1 (en) 1999-05-14 2003-11-18 Cytokinetics, Inc. Database system including computer code for predictive cellular bioinformatics
US6436629B1 (en) * 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
US7218764B2 (en) 2000-12-04 2007-05-15 Cytokinetics, Inc. Ploidy classification method
US6599694B2 (en) 2000-12-18 2003-07-29 Cytokinetics, Inc. Method of characterizing potential therapeutics by determining cell-cell interactions
US7016787B2 (en) 2001-02-20 2006-03-21 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US6956961B2 (en) 2001-02-20 2005-10-18 Cytokinetics, Inc. Extracting shape information contained in cell images
ES2185493B1 (es) * 2001-07-03 2004-06-16 Madrid Genetics, S.L. Metodo para evaluar in vitro en condiciones fisiologicas o patologicas relevantes la actividad biologica de compuestos a gran escala.
US20050014217A1 (en) 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
GB2423988A (en) 2003-07-18 2006-09-13 Cytokinetics Inc Characterizing biological stimuli by response curves
US7235353B2 (en) 2003-07-18 2007-06-26 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US7323318B2 (en) 2004-07-15 2008-01-29 Cytokinetics, Inc. Assay for distinguishing live and dead cells
US8679836B2 (en) 2007-10-01 2014-03-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures
KR102779236B1 (ko) * 2021-11-25 2025-03-12 쓰리이솔루션 주식회사 기능성 혈관이 도입된 인공피부 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539716A (en) * 1981-03-19 1985-09-10 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues
US4546500A (en) * 1981-05-08 1985-10-15 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix

Also Published As

Publication number Publication date
JP3404572B2 (ja) 2003-05-12
AU732538B2 (en) 2001-04-26
EP1023599A1 (en) 2000-08-02
CA2301171C (en) 2002-11-12
DK1023599T3 (da) 2002-07-08
NZ502962A (en) 2001-01-26
ATE218209T1 (de) 2002-06-15
MY119061A (en) 2005-03-31
DE69805644T2 (de) 2002-09-12
WO1999017116A1 (en) 1999-04-08
CA2301171A1 (en) 1999-04-08
EP1023599B1 (en) 2002-05-29
NO20001608D0 (no) 2000-03-28
GB9720987D0 (en) 1997-12-03
IL135386A0 (en) 2001-05-20
AU9178598A (en) 1999-04-23
JP2001518621A (ja) 2001-10-16
DE69805644D1 (de) 2002-07-04
ZA988936B (en) 1999-03-31
NO20001608L (no) 2000-03-28

Similar Documents

Publication Publication Date Title
ES2174486T3 (es) Ensayo multicelular in vitro de angiogenesis.
ATE331025T2 (de) Medium für die protein- und serumfreie zellkultur
EP0599651A3 (en) Bioreactor for cell culture in perfusion.
DK2055325T3 (da) Vævsregenerationssammensætning
ATE537453T1 (de) Selektion intrazellulärer immunglobuline
DE69725587D1 (de) Verwendung von wnt polypeptiden
Situ et al. Stimulation of murine tumour cell motility by laminin
DE69430322D1 (de) Chemilumineszenz-assay mittels energietransfer
MY148759A (en) Methods to culture circovirus
FR2659982B1 (fr) Utilisation de substrats chromogenes dans la determination de candida.
ATE226632T1 (de) Serumfreies medium für säugetierzellen
DE69631972D1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
DE3875396D1 (de) Mikrotraegermaterial fuer die zellkultur.
ATE304595T1 (de) Lichtproduzierender biosensor
PT1248852E (pt) Metodo de avaliacao de viabilidade de uma celula
DK0851028T3 (da) Immortaliseret human hornhindeepitalcellelinje
FR2716205B1 (fr) Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
PT880594E (pt) Vector retroviral e sua utilizacao em terapia genica
ATE344327T1 (de) Regulation der ausschleusung von proteinen
DE69634363D1 (de) Vorläufer von normalen neuralen epithelzellen
DE69826029D1 (de) Acetyl-coa-carboxylase von candida albicans
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
ES2047946T3 (es) Metodos de cultivos celulares para producir proteina c activada.
ES1038242U (es) Maqueta con base segmentada perfeccionada.
KR980000984U (ko) 효소 면역 자동분석기용 시험관 주사기

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1023599

Country of ref document: ES